Project Grant R34HL173389

Award Date 5/1/24
Completion Date 4/30/27
Dollars Obligated $847K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Forest Hills, TN 37215, USA
Similar Awards
This federal Project Grant award of $1,970,848 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to evaluate the efficacy of a digital intervention to increase physical activity and improve physical fitness in youth with Fontan circulation. The study, led by The Children's Hospital of Philadelphia (CHOP), will conduct a randomized controlled trial to determine if the multi-component digital intervention can increase...
This $374,592.00 Project Grant awarded by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program will support Dr. Lachant's research on an electronically-delivered home rehabilitation program for patients recovering from acute pulmonary embolism. The goal is to evaluate whether a prescriptive, gradually intensifying 8-week exercise program delivered remotely is more effective than regular electronic contact in reducing "post-PE...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing adherence to physical activity recommendations among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year, $809,029 award will support a 3-arm trial to assess whether interventions using...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $797,130 to The Children's Hospital of Philadelphia (CHOP) from September 2024 to June 2028. The project aims to implement and evaluate the real-world effectiveness of "single maintenance and reliever therapy" (SMART) for managing moderate-to-severe childhood asthma in a predominantly Black pediatric population. The study uses a...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $740,798 to The Miriam Hospital in Providence, RI to develop an adaptive intervention to help under-resourced cardiac rehabilitation patients maintain improvements in health behaviors after completing the initial rehabilitation program. The project will utilize a Sequential, Multiple Assignment, Randomized Trial (SMART) design to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $633,045 to the University of Pittsburgh to investigate the pathogenic mechanisms and therapeutic approaches for exercise intolerance in patients with post-acute sequelae of COVID-19 (PASC). The research aims to: 1) evaluate the predictive value of angiotensin-converting enzyme 2 (ACE2) activity as a biomarker for exercise...
This Project Grant award for $2,130,422 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to comprehensively evaluate lean muscle mass in patients with pulmonary arterial hypertension (PAH). The key objectives are: Characterize the endophenotype of PAH patients with low lean mass and identify the metabolomic signature, to provide insight into potential pathways. Assess the role of epicardial adipose tissue in the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $657,308 to The Children's Hospital of Philadelphia (CHOP) to conduct research on the CXCL12 signaling axis and its role in pulmonary arterial heterogeneity, development, and disease. The key objectives of this 12-month project are to: 1) define the spatiotemporal role of CXCL12 signaling in pulmonary vascular development, 2)...
This federal Project Grant award of $792,235 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development and execution of a randomized clinical trial to evaluate the effectiveness of a commercially available fitness mHealth app (Rehabbing with Peloton) for improving physical activity among individuals recovering from transcatheter aortic valve replacement (TAVR). The key products and services to be delivered under this grant include:...
This $2,256,023 Project Grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) federal grant program. The grant supports the development and testing of a "Mobile Cued Adherence Therapy (MCAT)" intervention to improve blood pressure medication adherence among Medicaid enrollees with hypertension. The primary awardee, Arizona State University (ASU), will partner with the Wellth smartphone app to deliver...

MHOVE-PPH STUDY: MOBILE HEALTH INTERVENTION TO IMPROVE EXERCISE IN PEDIATRIC PH - ABSTRACT ADOLESCENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) HAVE IMPAIRED EXERCISE CAPACITY AND REDUCED QUALITY OF LIFE. CURRENT THERAPIES ONLY MODESTLY IMPROVE EXERCISE CAPACITY AND ARE OFTEN PROHIBITIVELY EXPENSIVE, HIGHLIGHTING THE NEED FOR ADDITIONAL, COST-EFFECTIVE INTERVENTIONS. MULTIPLE STUDIES HAVE DEMONSTRATED THAT INCREASING PHYSICAL ACTIVITY IS HIGHLY EFFICACIOUS IN ADULT PAH, RESULTING IN SIX-MINUTE WALK DISTANCE (6MWD) IMPROVEMENT THAT EXCEEDS THE EFFECT OF MEDICATIONS. HOWEVER, PROTOCOLS REQUIRE INPATIENT REHABILITATION, MAKING THEM IMPRACTICAL AND POORLY SCALABLE TO THE ADOLESCENT PAH POPULATION. MOREOVER, CARDIOPULMONARY REHABILITATION IS POORLY REIMBURSED, AND FACILITIES ARE NOT EASILY AVAILABLE OR ACCOMMODATING OF ADOLESCENTS. RECENTLY, IN ADULTS, WE COMPLETED THE FIRST MOBILE HEALTH (MHEALTH) INTERVENTION IN THE PAH POPULATION, DEMONSTRATING THE EFFECTIVENESS OF LINKING REAL TIME ACTIVITY TRACKING WITH A "SMART" BEHAVIORAL COACHING INTERVENTION, USING PERSONALIZED, ENCOURAGING CONTENT BASED IN BEHAVIORAL CHANGE THEORY (E.G. FEEDBACK LOOPS AND HABIT FORMATION). AFTER 12 WEEKS, THE INTERVENTION ARM TOOK 1019 MORE STEPS PER DAY THAN THE CONTROL ARM (ADJUSTED FOR AGE, SEX, FUNCTIONAL CLASS, AND BASELINE STEP COUNTS), WITH

Posted 4/15/24, 12:00 AM